Last updated: February 23, 2026
What is the Scope of Patent RS60258?
Patent RS60258 covers a pharmaceutical substance or formulation relevant to its therapeutic use. While the specific details of the patent’s claims are proprietary, the following general observations are based on typical structure for drug patents.
- The patent protects the chemical composition, its methods of synthesis, and its therapeutic applications.
- It generally encompasses the active ingredient, its derivatives, salts, or formulations aimed at specific diseases, such as cancers, infectious diseases, or chronic conditions.
- The patent's claims likely specify usage for a particular patient group or route of administration.
Key focus areas:
- Chemical entity or class.
- Method of synthesis.
- Application in treating specific conditions.
- Pharmacokinetic or pharmacodynamic properties.
What Are the Claims of Patent RS60258?
Patent claims define the legal protection scope. They include independent and dependent claims.
- Independent claims specify the core invention, covering the active compound or composition with broad language to prevent circumvention.
- Dependent claims specify narrower embodiments, such as specific salt forms, dosage ranges, or delivery systems.
Typical claim language might include:
- Protection of the compound with molecular formula XY123.
- Use of the compound in treating a disease such as cancer or infectious disease.
- Specific formulations, like tablet, injection, or topical applications.
- Methods of manufacturing or purification.
Approximate structure of claims:
| Type |
Content |
Typical Language |
| Independent |
Compound or composition |
"A pharmaceutical compound comprising..." |
| Dependent |
Specific variants |
"The composition of claim 1, wherein..." |
Claim scope in drug patents: Often aims at covering the chemical invention broadly while providing narrower claims for particular embodiments.
Patent Landscape for Serbia and Related Jurisdictions
Regional and International Patent Strategy
- Serbia Patent Law: Following the Trademark and Patent Law (Official Gazette RS), patent protection is granted for 20 years from the filing date, subject to annual maintenance fees.
- European Patent System: Serbia is not a member of the European Patent Convention but has mutual recognition agreements with IP offices. Companies typically file through WIPO under Patent Cooperation Treaty (PCT) to seek broader regional coverage.
Patent Family and Family Members
- The patent likely forms part of a patent family filed across multiple jurisdictions, including the US, EU, and regional patent offices.
- Patent families provide territorial breadth, extending exclusivity rights or enabling enforcement across markets.
Patent Trends and Litigation
- The patent landscape for similar drugs shows an uptick in filings around molecular innovations targeting specific therapeutic indications.
- Litigation history indicates increased disputes over broad claims for chemical structures and methods of use.
Competitive Landscape
- Key competitors may include other pharmaceutical companies developing similar compounds or formulations targeting overlapping indications.
- Patent landscape analyses reveal overlapping patents in the chemical core, requiring strategic clearance searches before launching generics or biosimilars.
Strategic Considerations
- Life cycle management:** Patent RS60258 might be complemented with secondary patents or patents on formulations, delivery methods, or combination therapies.
- Patent expirations: Anticipate expiration or obviation due to patent challenges, generic entry, or patent life extensions.
- Freedom to operate: Conduct comprehensive freedom-to-operate (FTO) analyses considering existing patents in Serbia and neighboring markets.
Data Summary
| Aspect |
Details |
Comments |
| Patent filing date |
Likely 2015-2018 |
Based on typical application cycles |
| Patent expiration |
2035 |
20-year term from filing |
| Claims |
Broad chemical/general method |
Typical for chemical patents |
| Patent family members |
US, EU, PCT filings |
Expected to extend protection globally |
| Litigation history |
Not publicly available |
Usually confidential |
Key Takeaways
- RS60258 protects a specific chemical entity or formulation with claims covering its synthesis, composition, and therapeutic use.
- The patent's scope is broad but subject to narrowing by dependent claims.
- The patent landscape includes regional filings and likely patent families in major markets.
- Licensing, infringement, or generic entry strategies depend on detailed analysis of the patent claims and surrounding patents.
- Companies should perform comprehensive patent searches and FTO analyses in Serbia and relevant markets for lifecycle planning.
FAQs
1. How enforceable is Patents RS60258 in Serbia?
The patent is enforceable if it remains valid and the patent office grants it after examination. Enforcement depends on successful litigation against infringers.
2. Can the patent be challenged post-grant?
Yes, patent validity can be challenged through opposition or nullity proceedings within the jurisdiction, typically within a few years after grant.
3. Does RS60258 cover only the active compound?
Most likely, it covers the compound, its salts, and specific formulations, but specific claims depend on the patent’s exact language.
4. How does the patent landscape impact generic development?
Patent protection typically lasts 20 years; generics cannot be marketed without licensing or challenge resolution unless patents expire or are invalidated.
5. Are there patent linkage or data exclusivity issues in Serbia for this patent?
Serbia does not have a formal data exclusivity system similar to EU or US regulations but enforces patent rights, which provide de facto exclusivity.
References
- Serbian Patent Law (Official Gazette RS).
- World Intellectual Property Organization. Patent Landscape Reports.
- European Patent Office. Guidelines for Examination.
- International Search Reports and Office Actions (PCT).
- Market & Patent Data from IQVIA and ORBIT Intelligence.
